What community activism can achieve – ITPC’s 2017 Annual Review
ITPC is proud to share its 2017 Annual Review, titled What Community Activism Can Achieve. The report highlights our successes, challenges, and...
Read more about What community activism can achieve – ITPC’s 2017 Annual Review
Collective efforts by civil society groups bar the way to Hepatitis C patents
Many hold the view that Gilead’s revolutionary treatment against hepatitis C (sofosbuvir) marked the beginning of a shift in position...
Read more about Collective efforts by civil society groups bar the way to Hepatitis C patents
8 videos that explain the tension between HIV activists and Big Pharma
From Hollywood blockbusters, to investigative documentaries, to our own short, satirical animation, here are eight videos that show how the...
Read more about 8 videos that explain the tension between HIV activists and Big Pharma
Fixing the broken patent system: From Marrakech and back again
Marrakech was home to the signing of the TRIPS Agreement in 1995, an agreement that has been exploited by pharmaceutical...
Read more about Fixing the broken patent system: From Marrakech and back again
Storify: Pathways to Access #GSIPA2M
[View the story “Pathways to Access! #GSIPA2M (15-17 Jan 2018)” on Storify] SaveSave
Read more about Storify: Pathways to Access #GSIPA2M
IP and access to medicines: welcome speech
Our inaugural Global Summit on Intellectual Property and Access to Medicines has started today. Read Solange Baptiste’s welcoming speech below,...
Read more about IP and access to medicines: welcome speech
-
Pathways to Access: Our global summit on intellectual property and access to medicines
23 years after the Trade Related Aspects of Intellectual Property Rights (TRIPS) Agreement was signed in Morocco, our inaugural conference...
Read more about Pathways to Access: Our global summit on intellectual property and access to medicines
ICASA 2017: Optimal HIV treatment for ALL
As the 2017 International Conference on AIDS and STIs in Africa (ICASA) draws to a close in Abidja, Cote d’Ivoire,...
Read more about ICASA 2017: Optimal HIV treatment for ALL
New Study: Assessment of national intellectual property landscapes and their impact on access to medicines (Egypt, Morocco, Tunisia)
ITPC-MENA has released a comparative study of intellectual property provisions in Tunisia, Morocco and Egypt. The study was undertaken to...
Read more about New Study: Assessment of national intellectual property landscapes and their impact on access to medicines (Egypt, Morocco, Tunisia)
HIV activists trained on intellectual property and access to medicines
Demystifying intellectual property (IP) and providing advocacy tools. The International Treatment Preparedness Coalition – MENA (ITPC-MENA) with the support...
Read more about HIV activists trained on intellectual property and access to medicines